Previously referred to as MEDI2070 and AMG 139

( DrugBank: - / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	11

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	7

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

trials per page:

Showing 1 to 10 of 11 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-001866-14-ES (EUCTR)	27/10/2021	30/09/2020	Open-label Extension Study of Brazikumab in Crohn’s Disease	An Open-label, Long-term Extension Study of Brazikumab in Participants with Moderately to Severely A ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Limited	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	1000	Phase 3	China;Korea, Republic of;United States;Taiwan;Spain;Ukraine;Austria;Russian Federation;Israel;United ...
2	EUCTR2018-004346-42-IT (EUCTR)	03/09/2020	24/05/2021	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: [Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma INN or Propo ...	ALLERGAN LIMITED	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	2000	Phase 2;Phase 3	United States;Czechia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;France;Cz ...
3	EUCTR2018-004346-42-AT (EUCTR)	18/06/2020	21/01/2020	A study of the Efficacy and Safety of Brazikumab in Participants with Moderately to Severly Active C ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	Astrazeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	600	Phase 2;Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
4	EUCTR2018-004346-42-BG (EUCTR)	28/05/2020	08/01/2020	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Not Recruiting	Female: yes Male: yes	2000	Phase 2;Phase 3	United States;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;France;Czech Repu ...
5	EUCTR2018-004346-42-RO (EUCTR)	19/05/2020	18/03/2022	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Not Recruiting	Female: yes Male: yes	2000	Phase 2;Phase 3	United States;Czechia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;France;Cz ...
6	EUCTR2018-004346-42-BE (EUCTR)	15/04/2020	03/03/2020	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Not Recruiting	Female: yes Male: yes	2000	Phase 2;Phase 3	United States;Spain;Ukraine;Austria;Russian Federation;Israel;Italy;United Kingdom;France;Czech Repu ...
7	EUCTR2018-004346-42-ES (EUCTR)	26/12/2019	11/11/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	2000	Phase 2;Phase 3	United States;Serbia;Slovakia;Spain;Ukraine;Austria;Russian Federation;Israel;United Kingdom;Italy;F ...
8	EUCTR2018-004346-42-FR (EUCTR)	05/11/2019	10/07/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	2000	Phase 2;Phase 3	Serbia;United States;Slovakia;Spain;Ukraine;Austria;Russian Federation;Israel;Italy;United Kingdom;F ...
9	EUCTR2018-004346-42-GB (EUCTR)	10/09/2019	30/05/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	2000	Phase 2;Phase 3	United States;Serbia;Czechia;Slovakia;Spain;Ukraine;Austria;Russian Federation;Israel;United Kingdom ...
10	EUCTR2018-004346-42-PL (EUCTR)		01/08/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	NA	Female: yes Male: yes	2000	Phase 2;Phase 3	Russian Federation;Romania;Hungary;United States;Ukraine;United Kingdom;Spain;Canada;Austria;Czech R ...

First Previous1 2Next Last

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 7 of 7 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-001605-93-RO (EUCTR)	10/10/2019	15/03/2022	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Not Recruiting	Female: yes Male: yes	900	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Switzerland;Italy;India;France;Malaysi ...
2	EUCTR2018-001605-93-BG (EUCTR)	09/10/2019	20/09/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Not Recruiting	Female: yes Male: yes	375	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Switzerland;Italy;India;France;Malaysi ...
3	EUCTR2018-001605-93-IT (EUCTR)	26/09/2019	29/01/2021	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: [Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma INN or Propo ...	ALLERGAN LIMITED	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	375	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Switzerland;Italy;India;France;Malaysi ...
4	EUCTR2018-001605-93-BE (EUCTR)	23/09/2019	07/06/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	AstraZeneca AB	NULL	Not Recruiting	Female: yes Male: yes	375	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Italy;Switzerland;India;France;Malaysi ...
5	EUCTR2018-001605-93-FR (EUCTR)	13/09/2019	25/06/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	900	Phase 2	United States;Taiwan;Spain;Russian Federation;Israel;Colombia;Switzerland;Italy;India;France;Malaysi ...
6	EUCTR2018-001605-93-ES (EUCTR)	07/08/2019	09/08/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	900	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Italy;Switzerland;India;France;Malaysi ...
7	EUCTR2018-001605-93-GB (EUCTR)	01/07/2019	04/04/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	375	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Switzerland;Italy;India;France;Malaysi ...

First Previous1Next Last